BioPorto: Mission and Vision

BioPorto will constantly seek to select new diagnostic biomarker targets from the marketed antibody portfolio that have clinical relevance, potential for a large market in routine diagnostics and for patent protection and by this selection achieve as large a share of the routine diagnostic market as possible.



Investor Relations

To BioPorto, openness and transparency are essential in maintaining good relations with investors.

The purpose of Investor Relations and this website is to ensure that correct and adequate information about BioPorto is made available to all interested parties simultaneously, regularly and consistently.

BioPorto - Grusbakken 8, DK-2820 Gentofte, Denmark
Phone: (+45) 4529 0000 - Fax: (+45) 4529 0001 - Email: info@bioporto.com

Created by Wizkids ApShttp://wizkids.dk